Anat Ashkenazi
Executive Vice President and Chief Financial OfficeratEli Lilly & Co· In proxies 2021–2024
Pay in FY2024-35% from the year before
Anat Ashkenazi was paid $5.0M in FY2024 (Dec), down 35%.
PayNo stock prices for these years
Experience
- Eli Lilly & CoPublic company · 5 yr
- Executive Vice President and Chief Financial Officer2021 – Present · 5 yrNo stock prices for these years
- Maravai Lifesciences HoldingsPublic company · 3 yr
- Director2023 – Present · 3 yrNo stock prices for these years
- Varian Medical Systems, Inc.Public company · 3 yr
- Director2018 – 2021 · 3 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?